FDA: Medical Device Industry Tells Agency to Take a Time Out on User Fee Reauthorization

The medical device industry wants to hold user fees at current levels for two more years so the FDA can “resolve policy issues,” according to minutes from the Medical Device User Fee Reauthorization or MDUFMA III negotiation meetingThe medical device industry is asking the FDA to take a couple more years to meet goals it says the watchdog agency has failed to meet before it agrees on reauthorizing user fees for another go-around.

MORE ON THIS TOPIC